US Broker Ratings

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Exploring a 100% Upside Potential

Ascentage Pharma Group International (AAPG), a China-based biotechnology firm, is drawing significant attention from investors thanks to its promising pipeline and a compelling potential upside of 100.50%. Specializing in the..

Novavax, Inc. (NVAX) Stock Analysis: Unpacking a 36.68% Potential Upside

As the global race for vaccine innovation continues, Novavax, Inc. (NASDAQ: NVAX) stands out as a key player in the biotechnology sector. With its focus on developing vaccines to prevent..

ANI Pharmaceuticals (ANIP) Stock Analysis: Exploring a 53% Upside Potential

Investors with an eye on the healthcare sector might want to consider ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a noteworthy player in the specialty and generic drug manufacturing industry. With a..

Bausch Health Companies Inc. (BHC)

⚠️ No article content returned.

..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Exploring a 18.80% Potential Upside in the Biotech Sector

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a Canadian biopharmaceutical company, is making waves in the healthcare sector with its focus on treating autoimmune diseases, including lupus nephritis. With a current market..

Liquidia Corporation (LQDA) Stock Analysis: Exploring a Remarkable 3,054.60% Revenue Growth and 39.74% Upside Potential

Investors with a keen eye on the healthcare sector may find Liquidia Corporation (NASDAQ: LQDA) a compelling addition to their portfolios. As a biopharmaceutical enterprise specializing in treatments for rare..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring the 86% Potential Upside and Analyst Confidence

Schrodinger, Inc. (NASDAQ: SDGR), a pivotal player in the healthcare sector, particularly within the health information services industry, is capturing attention with its innovative approach to drug development and materials..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Exploring a 210% Potential Upside in Biotech

For investors seeking opportunities in the healthcare sector, ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) presents a compelling case. With an impressive potential upside of 210.34%, as indicated by analyst ratings, this..

Innoviva, Inc. (INVA) Investor Outlook: Analyzing Growth Potential and a 49.89% Upside

Innoviva, Inc. (NASDAQ: INVA), a burgeoning biopharmaceutical player in the healthcare sector, has caught the attention of investors with its notable growth trajectory and promising market position. Based in the..

agilon health, inc. (AGL) Stock Analysis: Potential 58% Upside Amidst Revenue Growth

For investors navigating the volatile waters of healthcare stocks, agilon health, inc. (NYSE: AGL) presents a tantalizing opportunity. With a projected potential upside of 58.63%, this healthcare provider might pique..

Opko Health, Inc. (OPK) Stock Analysis: A Glimpse into Potential 185% Upside

Opko Health, Inc. (NASDAQ: OPK), a Miami-based healthcare company, is making waves in the diagnostics and research industry. With a market capitalization of $913.56 million, Opko Health has captured investor..

Organon & Co. (OGN) Stock Analysis: Potential 41.96% Upside Amid Healthcare Sector Challenges

Investors eyeing opportunities in the healthcare sector may want to take a closer look at Organon & Co. (NYSE: OGN). With a market cap of $1.65 billion, this U.S.-based pharmaceutical..

Integra LifeSciences Holdings (IART) Stock Analysis: Unpacking the 65% Potential Upside in the Medical Devices Sector

Investors looking at the healthcare sector, particularly the medical devices industry, might find Integra LifeSciences Holdings Corporation (NASDAQ: IART) an intriguing prospect. Despite facing some headwinds, significant potential upside is..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A 40% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may want to keep a close eye on Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX). With a market capitalization of $3.76 billion, this global biopharmaceutical..

Teladoc Health, Inc. (TDOC) Stock Analysis: Exploring a Potential 32% Upside in the Virtual Healthcare Leader

Investors are keenly watching Teladoc Health, Inc. (NYSE: TDOC) as the company sits at a pivotal point in the evolution of virtual healthcare services. With a market capitalization of $961.56..

ACADIA Pharmaceuticals Inc. (ACAD): Investor Outlook Highlights 48.90% Potential Upside

Investors eyeing the healthcare sector’s biotechnology niche might find ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) a promising candidate, especially given its substantial potential upside. With a current market capitalization of $3.65..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Navigating the 35% Upside Potential

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands at the intersection of healthcare innovation and investment opportunity. As a prominent player in the medical devices industry, Tandem specializes in advanced insulin..

Evotec SE (EVO) Stock Analysis: Unlocking a Potential 115% Upside in Drug Discovery

Evotec SE (EVO), a prominent player in the healthcare sector, is making waves in the drug manufacturing industry with its focus on a wide array of therapeutic areas. Headquartered in..

Neogen Corporation (NEOG) Stock Analysis: Unpacking the 28% Potential Upside in the Healthcare Sector

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specializing in medical devices, has recently caught the attention of investors with a notable potential upside of approximately 28.06%...

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring 37% Upside Potential in Bioelectric Medicine

Pulse Biosciences, Inc (NASDAQ: PLSE) is a compelling player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $1.48 billion, this Miami-based..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds